These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10400139)

  • 21. CCR5delta32, CCR2-64I, and SDF1-3'A polymorphisms related to resistance to HIV-1 infection and disease in the Ecuadorian population.
    Paz-y-Mino C; Morillo SA; Celi AP; Witte T; Muñoz Guijarro MJ; Collantes JC; Leone PE
    Hum Biol; 2005 Aug; 77(4):521-6. PubMed ID: 16485782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of alleles associated with HIV resistance in Russia.
    Ryabov GS; Kazennova EV; Bobkova MR; Bobkov AF
    Genet Test; 2004; 8(1):73-6. PubMed ID: 15140377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene polymorphisms in CCR5, CCR2, SDF1 and RANTES among Chinese Han population with HIV-1 infection.
    Li H; Liu TJ; Hong ZH
    Infect Genet Evol; 2014 Jun; 24():99-104. PubMed ID: 24650919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of association of human chemokine receptor gene polymorphisms CCR2-64I and CCR5-Delta32 with autoimmune Addison's disease.
    Gambelunghe G; Ghaderi M; Gharizadeh B; Brozzetti A; Tortoioli C; Del Sindaco P; Sanjeevi CB; Hjelmström P; Sirsjö A; Nyren P; Santeusanio F; Falorni A
    Eur J Immunogenet; 2004 Apr; 31(2):73-6. PubMed ID: 15086346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution of four HIV type 1-resistance polymorphisms (CCR5-Delta32, CCR5-m303, CCR2-64I, and SDF1-3'A) in the Bahraini population.
    Salem AH; Farid E; Fadel R; Abu-Hijleh M; Almawi W; Han K; Batzer MA
    AIDS Res Hum Retroviruses; 2009 Oct; 25(10):973-7. PubMed ID: 19803715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of CCR5-delta32 and CCR2-64I alleles on disease progression of perinatally HIV-1-infected children: an international meta-analysis.
    Ioannidis JP; Contopoulos-Ioannidis DG; Rosenberg PS; Goedert JJ; De Rossi A; Espanol T; Frenkel L; Mayaux MJ; Newell ML; Pahwa SG; Rousseau C; Scarlatti G; Sei S; Sen L; O'Brien TR;
    AIDS; 2003 Jul; 17(11):1631-8. PubMed ID: 12853745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
    Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
    Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemokine receptor gene polymorphisms and risk of human T lymphotropic virus type I infection in Jamaica.
    Hisada M; Lal RB; Masciotra S; Rudolph DL; Martin MP; Carrington M; Wilks RJ; Manns A
    J Infect Dis; 2002 May; 185(9):1351-4. PubMed ID: 12001056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Genetic polymorphism of human immunodeficiency virus coreceptor CCR5Delta32 and CCR2-64I alleles in Chinese Yi Ethnic group in Sichuan].
    Deng XL; Hong KX; Chen JP; Ruan YH; Xu MY; Qin GM; Li K; Xing H; Shao YM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Dec; 25(12):1050-3. PubMed ID: 15769362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CCR5 and CCR2 gene polymorphisms in hypertensive patients.
    Mettimano M; Specchia ML; Ianni A; Arzani D; Ricciardi G; Savi L; Romano-Spica V
    Br J Biomed Sci; 2003; 60(1):19-21. PubMed ID: 12680626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of CCR2 genotype in the clinical course of syncytium-inducing (SI) or non-SI human immunodeficiency virus type 1 infection and in the time to conversion to SI virus variants.
    van Rij RP; de Roda Husman AM; Brouwer M; Goudsmit J; Coutinho RA; Schuitemaker H
    J Infect Dis; 1998 Dec; 178(6):1806-11. PubMed ID: 9815240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotypes of CCR2 and CCR5 chemokine receptors in human myasthenia gravis.
    Zhao X; Gharizadeh B; Hjelmström P; Pirskanen R; Nyrén P; Lefvert AK; Ghaderi M
    Int J Mol Med; 2003 Nov; 12(5):749-53. PubMed ID: 14533004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allelic distribution of CCR5 and CCR2 genes in an Italian population sample.
    Romano-Spica V; Ianni A; Arzani D; Cattarini L; Majore S; Dean M
    AIDS Res Hum Retroviruses; 2000 Jan; 16(2):99-101. PubMed ID: 10659048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of polymorphisms in MCP-1, CCR2, and CCR5 genes with the risk and clinicopathological characteristics of prostate cancer.
    Kucukgergin C; Isman FK; Cakmakoglu B; Sanli O; Seckin S
    DNA Cell Biol; 2012 Aug; 31(8):1418-24. PubMed ID: 22612293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution of CCR5delta32, CCR2-64I and SDF1-3'A and plasma levels of SDF-1 in HIV-1 seronegative North Indians.
    Verma R; Gupta RB; Singh K; Bhasin R; Anand Shukla A; Chauhan SS; Luthra K
    J Clin Virol; 2007 Mar; 38(3):198-203. PubMed ID: 17240189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.
    Promrat K; McDermott DH; Gonzalez CM; Kleiner DE; Koziol DE; Lessie M; Merrell M; Soza A; Heller T; Ghany M; Park Y; Alter HJ; Hoofnagle JH; Murphy PM; Liang TJ
    Gastroenterology; 2003 Feb; 124(2):352-60. PubMed ID: 12557141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of CCR5delta32, CCR5m303, CCR2-64I and SDF1-3'A gene polymorphism on the prognosis of Chinese HIV-1 carriers].
    Wang XH; Feng TJ; Wang FS; Chen L; Shi XD; Jin L
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Sep; 19(3):256-9. PubMed ID: 16261210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of chemokine receptor gene polymorphisms on the response to potent antiretroviral therapy.
    O'Brien TR; McDermott DH; Ioannidis JP; Carrington M; Murphy PM; Havlir DV; Richman DD
    AIDS; 2000 May; 14(7):821-6. PubMed ID: 10839590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of chemokine receptor CCR2 and CCR5 gene polymorphism on allograft outcome in North Indian renal transplant recipients.
    Singh R; Kapoor R; Srivastava A; Mittal RD
    Scand J Immunol; 2009 Jan; 69(1):51-6. PubMed ID: 19037908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation.
    Kostrikis LG; Huang Y; Moore JP; Wolinsky SM; Zhang L; Guo Y; Deutsch L; Phair J; Neumann AU; Ho DD
    Nat Med; 1998 Mar; 4(3):350-3. PubMed ID: 9500612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.